Vektor Medical Secures $16M in Series A Funding to Revolutionize Cardiac Care with AI-Based Arrhythmia Analysis Technology.

Vektor Medical is at the forefront of non-invasive, AI-based arrhythmia analysis technology.

Source: Vektor Medical

Company Name: Vektor Medical
Location: San Diego, CA
Sector: Healthcare Technology
Funding Details: Raised $16m in Series A funding, co-led by Solas BioVentures and TVM Capital Life Science.
Purpose of Investment: To commercialize vMap®, Vektor’s AI-based arrhythmia analysis tool, including increasing clinical support, conducting additional clinical studies, and securing reimbursement.

Leadership: CEO Rob Krummen
Product: vMap, an FDA-cleared, non-invasive AI-based solution for arrhythmia localization and analysis using a 12-lead ECG. It provides physicians with critical information for understanding arrhythmia sources and optimizing cardiac ablation outcomes.

About Company: Vektor Medical is at the forefront of non-invasive, AI-based arrhythmia analysis technology. Their flagship product, vMap, aims to transform cardiac care by improving outcomes, optimizing workflows, and increasing procedural efficiency.

Pelotero Secures $3M in Seed Funding for AI-Powered Player Intelligence Platform

Pelotero is pioneering the integration of AI with sports coaching to create personalized training experiences.

Brenig Therapeutics Secures $65M in Series A Funding for Neurology Drug Development

Brenig Therapeutics is a neurology-focused drug development company utilizing an AI/ML-based discovery platform,

Monarch Tractor Secures $133M in Series C Funding for AI-Driven Agricultural Expansion

Monarch Tractor is pioneering the transformation of the agricultural industry by integrating AI and autonomous technology into its electric vehicle solutions, thus enhancing farm management and sustainability practices globally.

Read next